Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yexi Chen"'
Autor:
Zeqi Ji, Lingzhi Chen, Qiuping Yang, Huiting Tian, Jinyao Wu, Daitian Zheng, Jiehui Cai, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology. 12
BackgroundRecently, ctDNA has become the focus for scientists with respect to personalized treatment, early screening, precise diagnosis, and prognosis of BC. This paper aims to use bibliometric analysis to investigate the research status and future
Autor:
Jinyao Wu, Yaokun Chen, Lingzhi Chen, Zeqi Ji, Huiting Tian, Daitian Zheng, Qiuping Yang, Yiyuan Liu, Jiehui Cai, Jiehua Zheng, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology. 12
In recent years, anti-PD-1/anti-PD-L1 has been considered to be a valuable therapeutic target and prognostic indicator for triple-negative breast cancer. We analyzed all publications published in the field from their inception until the present day i
Autor:
Yaokun Chen, Weixun Lin, Xiao-Qi Lin, Yexi Chen, Juan Zou, Zhiyang Li, Jiehui Cai, Jiehua Zheng
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Studies have shown that patients with chronic renal failure (CRF) are more likely to suffer from breast cancer and other malignant tumors. To our knowledge, CRF can reduce drug excretion, thereby increase drug exposure and lead to increase
Autor:
Shangbo Xu, Yiyuan Liu, Taofeng Zhang, Jiehua Zheng, Weixun Lin, Jiehui Cai, Juan Zou, Yaokun Chen, Yanna Xie, Yexi Chen, Zhiyang Li
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe burden of breast cancer has been increasing globally. The epidemiology burden and trends need to be updated. This study aimed to update the burden and trends of breast cancer incidences, deaths, and disability-adjusted life-years (DALYs
Autor:
Hui Han, Yexi Chen, Jiayu Sun, Fen Yao, Weitao Shen, Kaihuang Lin, Yumeng Yuan, Xiaoyang Jiao, Juan Zou, Zhiyang Li
Publikováno v:
Translational Oncology, Vol 13, Iss 5, Pp-(2020)
Translational Oncology
Translational Oncology
OBJECTIVE: Intestinal microbiota plays a vital role in the pathogenesis of colorectal cancer (CRC), which is crucial for assessing the risk and prognosis of CRC. Most studies regarding human gut microbiota mainly based on the feces, but the exact com
Publikováno v:
OncoTargets and therapy
Yijie Huang,1,* Yexi Chen,2,* Xiaoqi Lin,2 Qingjun Lin,2 Ming Han,2 Guohu Guo2 1Department of General Surgery, Guangdong General Hospital, Guangzhou, 2Department of General Surgery, The Second Affiliated Hospital of Shantou University Medical College